[Mindray Medical International Limited December30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr.Pradip Bhaumikecialunsel, Office of Global Security Risk Division ofrporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December31, 2012 Filed April8, 2013]
[Mindray Medical International Limited December30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr.Pradip Bhaumikecialunsel, Office of Global Security Risk Division ofrporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December31, 2012 Filed April8, 2013]
[Mindray Medical International Limitedmment 1: You stated in your letter to usted January19, 2011, that your non-U.S. operations sold products andmponents to distributors located in Cuba, Sudan, and Syria. You disclose that certain of your distributors are located in ornduct business with thoseuntries. you know, Cuba, Sudan and Syria are designated stateonsors of terrorism by]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutionsopted at its annual general meeting of shareholders held in Hong Kong on December17, 2013. re-election STYLE="font-family:Times New Roman" SIZE="2">At the meeting, Mindray shareholders approved the Indition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers thempanys independent]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutionsopted at its annual general meeting of shareholders held in Hong Kong on December17, 2013. re-election STYLE="font-family:Times New Roman" SIZE="2">At the meeting, Mindray shareholders approved the Indition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers thempanys independent]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutionsopted at its annual general meeting of shareholders held in Hong Kong on December17, 2013. re-election At the meeting, Mindray shareholders approved the Indition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers thempanys independent registered public accounting]
[(Name of Issuer) Sponsored ADR (Title of Class of Securities) 602675100 (CUSIP Number) 26 November 2013 (Date of Event Which Requires Filing of this Statement) Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and]
[(Name of Issuer) Sponsored ADR (Title of Class of Securities) 602675100 (CUSIP Number) 26 November 2013 (Date of Event Which Requires Filing of this Statement) Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and]
